MedPath

Propofol

Propofol Injectable Emulsion, USPRx only

Approved
Approval ID

475de1f2-9b88-455a-ba3c-48e96083c056

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 15, 2021

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Propofol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50090-4569
Application NumberANDA205307
Product Classification
M
Marketing Category
C73584
G
Generic Name
Propofol
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateFebruary 29, 2020
FDA Product Classification

INGREDIENTS (6)

PROPOFOLActive
Quantity: 10 mg in 1 mL
Code: YI7VU623SF
Classification: ACTIB
SODIUM BENZOATEInactive
Code: OJ245FE5EU
Classification: IACT
GLYCERINInactive
Quantity: 22.5 mg in 1 mL
Code: PDC6A3C0OX
Classification: IACT
EGG PHOSPHOLIPIDSInactive
Quantity: 12 mg in 1 mL
Code: 1Z74184RGV
Classification: IACT
SOYBEAN OILInactive
Quantity: 100 mg in 1 mL
Code: 241ATL177A
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Propofol - FDA Drug Approval Details